Showing results (41-50 of 322) with videos related to
Sort By:
Pageof 33
Cancer Research and Treatment|September 25, 2020
Prognostic Impact of Age at the Time of Diagnosis in Korean Patients with Diffuse Large B-cell Lymphoma in the Rituximab Era: A Single Institution StudyHee Sang Hwang, Meejeong Kim, Chan-Sik Park, et al.International Journal of Hematology|January 29, 2013
High-dose chemotherapy and autologous stem-cell transplantation in Korean patients with relapsed or refractory Hodgkin lymphomaKwonoh Park, Dok Hyun Yoon, Shin Kim, et al.Journal of Korean Medical Science|April 2, 2010
Clinical characteristics of monomorphic post-transplant lymphoproliferative disordersJung-Hye Choi, Byeong-Bae Park, Cheolwon Suh, et al.Investigational New Drugs|May 22, 2010
Fatal interstitial pneumonitis in a patient with relapsed diffuse large B cell lymphoma following yttrium-90 ibritumomab tiuxetanMoon Jin Kim, Gyeong-Won Lee, Jong Woo Seo, et al.The Korean Journal of Internal Medicine|July 1, 2011
False-positive hypermetabolic lesions on post-treatment PET-CT after influenza vaccinationJeong-Eun Kim, Eun Kyoung Kim, Dae Ho Lee, et al.Anticancer Research|October 4, 2011
Erlotinib in first-line therapy for non-small cell lung cancer: a prospective phase II studyDae Ro Choi, Dae Ho Lee, Chang-Min Choi, et al.Blood Research|December 31, 2014
Case series of precursor B-cell lymphoblastic lymphomaJin Yong Kim, Sang Yong Om, Su-Jin Shin, et al.Cancer Research and Treatment|January 17, 2012
Phase II Study of S-1 Plus Either Irinotecan or Docetaxel for Non-small Cell Lung Cancer Patients Treated with More Than Three Lines of TreatmentDal Yong Kim, Dae Ho Lee, Sun-Joo Jang, et al.Cancer Science|June 11, 2013
Receptor tyrosine kinases MET and RON as prognostic factors in diffuse large B-cell lymphoma patients receiving R-CHOPYoung Wha Koh, Hee Sang Hwang, Se Jin Jung, et al.Hematological Oncology|April 13, 2017
Complete metabolic response (CMR) in positron emission tomography-computed tomography (PET-CT) scans may have prognostic significance in patients with marginal zone lymphomas (MZL)Ji Hyun Park, Shin Kim, Jin Sook Ryu, et al.Pageof 33